We are live on ! Find out more
Millennium Management

Millennium Management Portfolio holdings

AUM $240B
1-Year Est. Return 35.51%
 

Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.

This Fund
S&P 500
This Quarter Est. Return
+7.29%
1 Year Est. Return
+35.51%
3 Year Est. Return
+105.02%
5 Year Est. Return
+129.21%
10 Year Est. Return
+672.54%
AUM
$163B
AUM Growth
+$23.3B
Cap. Flow
+$13.3B
Cap. Flow %
8.14%
Top 10 Hldgs %
19.78%
Holding
7,530
New
1,693
Increased
2,343
Reduced
2,157
Closed
1,074

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$1.21B
2
VAR
Varian Medical Systems, Inc.
VAR
+$351M
3
RP
RealPage, Inc.
RP
+$316M
4
SHOP icon
Shopify
SHOP
+$312M
5
BA icon
Boeing
BA
+$310M

Sector Composition

Rank Sector Weight
1 Technology 7.82%
2 Healthcare 7.16%
3 Financials 5.78%
4 Consumer Discretionary 5.64%
5 Industrials 4.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CAHCW
6326
CALL
DELISTED
CA Healthcare Acquisition Corp. Warrant
CAHCW
$49K ﹤0.01%
+50,000
New +$46.6K
ATHE
6327
Alterity Therapeutics
ATHE
$83M
$48K ﹤0.01%
+3,694
New +$50.1K
VYNT
6328
DELISTED
Vyant Bio, Inc. Common Stock
VYNT
$48K ﹤0.01%
+2,556
New +$47.6K
CMPOW
6329
CALL
DELISTED
CompoSecure Inc Warrant
CMPOW
$45K ﹤0.01%
+27,500
New +$33K
CSCI
6330
DELISTED
COSCIENS Biopharma Inc. Common Stock
CSCI
$45K ﹤0.01%
515
-1,628
-76% -$155K
AAU
6331
DELISTED
Almaden Minerals Ltd
AAU
$45K ﹤0.01%
89,017
+37,847
+74% +$20.2K
BGSX.WS
6332
CALL
DELISTED
Build Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one Class A common stock at an exercise price of $11.50
BGSX.WS
$45K ﹤0.01%
+50,000
New +$44.2K
BXRX
6333
DELISTED
Baudax Bio, Inc. Common Stock
BXRX
$45K ﹤0.01%
42
+28
+200% +$36.6K
CYPH
6334
Cypherpunk Technologies Inc
CYPH
$64.7M
$44K ﹤0.01%
2,698
-5,547
-67% -$93.6K
NH
6335
DELISTED
NantHealth, Inc
NH
$44K ﹤0.01%
+1,270
New +$50.5K
WARR.WS
6336
CALL
DELISTED
Warrior Technologies Acquisition Company Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
WARR.WS
$44K ﹤0.01%
+58,525
New +$35.5K
SFRWW
6337
CALL
DELISTED
Appreciate Holdings, Inc. Warrant
SFRWW
$43K ﹤0.01%
+41,666
New +$34.5K
REED
6338
DELISTED
Reeds, Inc. Common Stock
REED
$43K ﹤0.01%
838
-12
-1% -$617
GIIXW
6339
CALL
DELISTED
Gores Holdings VIII, Inc. Warrant
GIIXW
$43K ﹤0.01%
+33,335
New +$38.2K
OHPAW
6340
CALL
DELISTED
Orion Acquisition Corp. Warrant
OHPAW
$43K ﹤0.01%
+45,370
New +$40.5K
BLRX
6341
BioLineRX
BLRX
$12.6M
$42K ﹤0.01%
+373
New +$43.8K
CFIVW
6342
CALL
DELISTED
CF Acquisition Corp. IV Warrant
CFIVW
$42K ﹤0.01%
38,408
NBRV
6343
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$42K ﹤0.01%
+1,245
New +$46.4K
ADVM
6344
DELISTED
Adverum Biotechnologies
ADVM
$40K ﹤0.01%
+1,149
New +$61.9K
ARMP icon
6345
Armata Pharmaceuticals
ARMP
$175M
$40K ﹤0.01%
10,055
-5,346
-35% -$22.5K
KIII
6346
CALL
DELISTED
Kismet Acquisition Three Corp. Class A Ordinary Shares
KIII
$40K ﹤0.01%
+49,000
New +$475K
YQ
6347
17 Education & Technology Group
YQ
$19.8M
$38K ﹤0.01%
523
-4,465
-90% -$479K
FURY
6348
Fury Gold Mines
FURY
$101M
$37K ﹤0.01%
+30,634
New +$39.6K
PFIE
6349
DELISTED
Profire Energy, Inc
PFIE
$37K ﹤0.01%
33,048
-170,181
-84% -$196K
MNDO icon
6350
Mind CTI
MNDO
$21.4M
$36K ﹤0.01%
11,619
+1,173
+11% +$3.53K

Similar funds

Millennium Management's Q2 2021 Portfolio in Review

As of Q2 2021, Millennium Management held 7,530 positions worth $163B, up 17% from $140B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Millennium Management deployed $13.3B of net new capital in Q2 2021, opening 1,693 new positions and adding to 2,343 existing holdings. Its largest new stake was SiteOne Landscape Supply: 609,104 shares worth $103M.

By sector, the portfolio is most concentrated in Technology at 7.8% of assets, down from 8.9% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Apple, an estimated $1.21B trimmed.

  • Millennium Management's largest Q2 2021 buy was SiteOne Landscape Supply: 609,104 shares worth $103M.
  • Millennium Management added most to Linde in Q2 2021, an estimated $770M increase.
  • Millennium Management's biggest Q2 2021 reduction was Apple, cutting an estimated $1.21B.
  • Millennium Management fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $351M.
  • Millennium Management's ten largest holdings make up 20% of its $163B portfolio in Q2 2021.
  • Millennium Management opened 1,693 new positions and closed 1,074 in Q2 2021.
  • Millennium Management's portfolio value rose 17% quarter-over-quarter to $163B.

Based on Millennium Management's 13F filing for Q2 2021, filed 16 Aug 2021.